Deciphering the Human Internet

G3 leverages molecular profiles of human health and disease to develop life changing diagnostics and therapeutics.

Integrated Omics
Big Data
Advanced Analytics

Embracing next generation genomics, transcriptomics, proteomics, metabolomics, and lipidomics to create digital models of biological pathways, the new standard to unravel the mysteries of human diseases.

Multi-faceted Diseases | Multi-faceted Platform

About Us

G3 is doing something different. We are shifting the conventional one dimensional look at biology and disease to a multi-dimensional approach, looking at disease from each angle. From your DNA, to how your DNA is expressed, to how disease develops and everything in between. By understanding biological networks, we are working towards the advancement of global human health.

Management Team

Scientific Advisory Board

Global Genomics Group is guided by a panel of experts on our Scientific Advisory Board, including:

Mario Alberto Accardi, Ph.D.; CEO and Co-founder of Orthonika, Partner at venture capital fund Fort Rock Capital and Visiting Researcher at Imperial College London

Aruna Bansal, MSc, Ph.D., CStat, CSci; Acclarogen Ltd, St John’s Innovation Centre, UK.

Michael R. Barnes, Ph.D.;Director of Bioinformatics, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, John Vane Science Centre, UK.

Brett R. Blackman, Ph.D.; Visiting Associate Professor of Biomedical Engineering, University of Virginia; Chief Scientific Officer & Co-Founder, HemoShear.

Abel De La Rosa, Ph.D.; Chief Scientific Officer, Emory Institute for Drug Development; Drug Innovation Ventures at Emory; Emory University.

Sergio Fazio, M.D., Ph.D.; William and Sonja Connor Chair of Preventative Cardiology, Professor of Medicine and Physiology & Pharmacology; Director, Center of Preventative Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University.

Sekar Kathiresan, M.D.; Associate Professor of Medicine, Harvard Medical School; Director, Preventive Cardiology, Massachusetts General Hospital; Associate Member, Broad Institute.

Pál Maurovich-Horvat, M.D., Ph.D., M.P.H.; Heart and Vascular Center, Semmelweis University, Hungary.

Sarah S. Murray, Ph.D.; Director, Genomic Technologies, Associate Professor, Department of Pathology, Center for Advanced Laboratory Medicine, University of California San Diego.

Arshed Quyyumi, M.D., F.A.C.C., F.R.C.P.; Co-Director, Emory Clinical Cardiovascular Research Institute; Professor of Medicine, Division of Cardiology, Emory University School of Medicine.

Tim D. Spector M.B.B.S., M.D., MSc , F.R.C.P., Department of Twin Research & Genetic Epidemiology, Kings College London, St Thomas’ Hospital, London, UK.

James B. Strait, M.D., Ph.D.; Senior Medical Scientific Expert, Novartis; Cardiology Consultant, National Institute of Health (NIH).

Norman C.W. Wong, M.D., F.R.C.P.; Professor of Medicine and Biochemistry & Molecular Biology; Director, Libin Gene Therapy Unit, University of Calgary.

Research & Development


The GLOBAL Clinical Study

The GLOBAL Clinical Study is an active prospective, large, multi-center international study recruiting up to 10,000 patients that aims to characterize cardiovascular, cardio-metabolic, liver, and bone disease.

Link to the study: www.clinicaltrials.gov | NCT01738828

Press & News



Thanks for looking. We’d love to hear from you.

Corporate Affairs Contact
Idean Marvasty, Vice President of Finance & Operations

Clinical Affairs Contact
Bradley Brown, Vice President of Clinical Affairs